Shandong Weigao Medical Polymer Co logo

1066 - Shandong Weigao Medical Polymer Co Share Price

HK$16.14 -0.4  -2.3%

Last Trade - 18/09/20

Sector
Healthcare
Size
Large Cap
Market Cap £7.26bn
Enterprise Value £7.25bn
Revenue £1.20bn
Position in Universe 185th / 5985
Bullish
Bearish
Unlock 1066 Revenue
Momentum
Relative Strength (%)
1m -12.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -28.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
5,278 5,919 5,620 6,293 8,809 10,364 11,353 13,559 +14.4%
+24.6 +13.0 -16.5 -16.0 +84.4 +38.0 +6.71 +23.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Shandong Weigao Group Medical Polymer Co revenues increased 3% to RMB5.09B. Net income increased 4% to RMB970M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Distribution costs decrease of 11% to RMB1.18B (expense), Administrative expenses - Balancing valu decrease of 16% to RMB302.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 1066
Graphical History

Revenue

1066 Revenue Unlock 1066 Revenue

Net Income

1066 Net Income Unlock 1066 Revenue

Normalised EPS

1066 Normalised EPS Unlock 1066 Revenue

PE Ratio Range

1066 PE Ratio Range Unlock 1066 Revenue

Dividend Yield Range

1066 Dividend Yield Range Unlock 1066 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
1066 EPS Forecasts Unlock 1066 Revenue
Profile Summary

Shandong Weigao Group Medical Polymer Co., Ltd. is principally engaged in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. The Company operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The Company is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated December 28, 2000
Public Since February 27, 2004
No. of Shareholders: n/a
No. of Employees: 10,103
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Hang Seng Composite , Hang Seng Composite LargeCap & MidCap , Hang Seng Mainland 100 , Hang Seng Composite MidCap , Hang Seng Composite Mid & SmallCap ,
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 4,522,332,324
Free Float (0.0%)
Eligible for
ISAs
SIPPs
1066 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 1066
Upcoming Events for 1066
Wednesday 14th October, 2020
Dividend For SHWGY.PK - 0.0360 USD
Thursday 15th October, 2020
Dividend For SHWGY.PK - 0.0363 USD
Thursday 15th October, 2020
Dividend For 1066.HK - 0.0620 CNY
Frequently Asked Questions for Shandong Weigao Medical Polymer Co
What is the Shandong Weigao Medical Polymer Co share price?

As of 18/09/20, shares in Shandong Weigao Medical Polymer Co are trading at HK$16.14, giving the company a market capitalisation of £7.26bn. This share price information is delayed by 15 minutes.

How has the Shandong Weigao Medical Polymer Co share price performed this year?

Shares in Shandong Weigao Medical Polymer Co are currently trading at HK$16.14 and the price has moved by 89.21% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Shandong Weigao Medical Polymer Co price has moved by 88.82% over the past year.

What are the analyst and broker recommendations for Shandong Weigao Medical Polymer Co?

Of the analysts with advisory recommendations for Shandong Weigao Medical Polymer Co, there are there are currently 4 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Shandong Weigao Medical Polymer Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Shandong Weigao Medical Polymer Co next release its financial results?

Shandong Weigao Medical Polymer Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Shandong Weigao Medical Polymer Co dividend yield?

The Shandong Weigao Medical Polymer Co dividend yield is 0.43% based on the trailing twelve month period.

Does Shandong Weigao Medical Polymer Co pay a dividend?

Last year, Shandong Weigao Medical Polymer Co paid a total dividend of 0.06, and it currently has a trailing dividend yield of 0.43%. Looking ahead, shares in Shandong Weigao Medical Polymer Co are due to go ex-dividend on 2020-10-16 and the next dividend pay date is 2020-11-20.

When does Shandong Weigao Medical Polymer Co next pay dividends?

Shandong Weigao Medical Polymer Co are due to go ex-dividend on 2020-10-16 and the next dividend pay date is 2020-11-20. The historic dividend yield on Shandong Weigao Medical Polymer Co shares is currently 0.43%.

How do I buy Shandong Weigao Medical Polymer Co shares?

To buy shares in Shandong Weigao Medical Polymer Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Shandong Weigao Medical Polymer Co?

Shares in Shandong Weigao Medical Polymer Co are currently trading at HK$16.14, giving the company a market capitalisation of £7.26bn.

Where are Shandong Weigao Medical Polymer Co shares listed? Where are Shandong Weigao Medical Polymer Co shares listed?

Here are the trading details for Shandong Weigao Medical Polymer Co:

Country of listing: Hong Kong
Exchange: HKG
Ticker Symbol: 1066
What kind of share is Shandong Weigao Medical Polymer Co?

Based on an overall assessment of its quality, value and momentum, Shandong Weigao Medical Polymer Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Shandong Weigao Medical Polymer Co share price forecast 2020?

Shares in Shandong Weigao Medical Polymer Co are currently priced at HK$16.14. At that level they are trading at 15.2% discount to the analyst consensus target price of 0.00.

Analysts covering Shandong Weigao Medical Polymer Co currently have a consensus Earnings Per Share (EPS) forecast of 0.473 for the next financial year.

How can I tell whether the Shandong Weigao Medical Polymer Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shandong Weigao Medical Polymer Co. Over the past six months, the relative strength of its shares against the market has been 15.16%. At the current price of HK$16.14, shares in Shandong Weigao Medical Polymer Co are trading at 20.75% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Shandong Weigao Medical Polymer Co PE Ratio?

The Shandong Weigao Medical Polymer Co PE ratio based on its reported earnings over the past 12 months is 1.76. The shares are currently trading at HK$16.14.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Shandong Weigao Medical Polymer Co?

Shandong Weigao Medical Polymer Co's management team is headed by:

Hua Wei Zhang - CHM
Yi Wang - VCH
Shu Hua Zhou - NED
Miu Ling Wong - SEC
Wai Hung Lo - NID
Hong Feng Ju - DGM
Ming Zhong Fu - NID
Jin xia Wang - NID
Jian Bo Gong - EDR
Xue Feng Wu - CFO
Jing Long - CEO
Who are the major shareholders of Shandong Weigao Medical Polymer Co?

Here are the top five shareholders of Shandong Weigao Medical Polymer Co based on the size of their shareholding:

Weigao Holding Co Ltd Corporation
Percentage owned: 46.43% (2.10bn shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 1.8% (81.4m shares)
Schroder Investment Management (Hong Kong) Ltd. Investment Advisor/Hedge Fund
Percentage owned: 1.44% (65.2m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 0.98% (44.2m shares)
INVESCO Greater China Equity Fund Mutual Fund
Percentage owned: 0.9% (40.6m shares)
Similar to 1066
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.